EP4049673
GLP-1 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF POST-PRANDIAL HYPOGLYCEMIA OR CONGENITAL HYPERINSULINISM
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.1.2008EP published:
28.1.2026EP application number:
22156122.8
EPO information:
European Patent Register
Max expiry date:
7.1.2028
Title in English:
GLP-1 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF POST-PRANDIAL HYPOGLYCEMIA OR CONGENITAL HYPERINSULINISMLanguage of the patent:
English
Timeline
Today
8.1.2008EP application
28.1.2026EP Publication
Owner
Name:
The Trustees of the University of PennsylvaniaAddress:
3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283, US
Name:
Children's Hospital of PhiladelphiaAddress:
3401 Civic Center Boulevard, Philadelphia, PA 19104, US
Inventor
Name:
STOFFERS, DorisAddress:
Moorestown 08057, US
Name:
DE LEON, Diva DAddress:
Penn Valley 19072, US
Name:
STANLEY, CharlesAddress:
Drexel Hill 19026, US
Priority
Number:
87903307 PDate:
8.1.2007Country:
US
Classification
Categories:
A61K 38/26, A61P 3/10